Breath profile as composite biomarkers for lung cancer diagnosis
Authors:
- 1 April 2021
- journal article
- research article
- Published by Elsevier in Lung Cancer
- Vol. 154, 206-213
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Hunan Province
- National Natural Science Foundation of China
- Scientific Research Foundation of Hunan Provincial Education Department
This publication has 53 references indexed in Scilit:
- Release and uptake of volatile organic compounds by human hepatocellular carcinoma cells (HepG2) in vitroCancer Cell International, 2013
- Dependence of exhaled breath composition on exogenous factors, smoking habits and exposure to air pollutantsJournal of Breath Research, 2012
- Molecular analysis of volatile metabolites released specifically by staphylococcus aureus and pseudomonas aeruginosaBMC Microbiology, 2012
- The National Lung Screening Trial: Overview and Study DesignRadiology, 2011
- Breath gas aldehydes as biomarkers of lung cancerInternational Journal of Cancer, 2010
- Diagnosing lung cancer in exhaled breath using gold nanoparticlesNature Nanotechnology, 2009
- Release of volatile organic compounds (VOCs) from the lung cancer cell line CALU-1 in vitroCancer Cell International, 2008
- Detection of Lung Cancer by Sensor Array Analyses of Exhaled BreathAmerican Journal of Respiratory and Critical Care Medicine, 2005
- Volatile organic compounds in breath as markers of lung cancer: a cross-sectional studyThe Lancet, 1999
- Alveolar Gradient of Pentane in Normal Human BreathFree Radical Research, 1994